Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
The closing price of Cardinal Health, Inc (NYSE: CAH) was $151.57 for the day, down -0.90% from the previous closing price of $152.95. In other words, the price has decreased by -$0.90 from its previous closing price. On the day, 3.33 million shares were traded. CAH stock price reached its highest trading level at $153.68 during the session, while it also had its lowest trading level at $151.56.
Ratios:
Our analysis of CAH’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 9.34 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 19.56. For the most recent quarter (mrq), Quick Ratio is recorded 0.50 and its Current Ratio is at 0.94.
On February 05, 2025, Jefferies Upgraded its rating to Buy which previously was Hold and also upped its target price recommendation from $140 to $150.
TD Cowen Upgraded its Hold to Buy on January 08, 2025, whereas the target price for the stock was revised from $130 to $144.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Aug 20 ’25 when WEITZMAN DEBORAH bought 21,367 shares for $150.53 per share.
WEITZMAN DEBORAH sold 21,367 shares of CAH for $3,216,375 on Aug 20 ’25. The CEO, PSS Segment now owns 53,428 shares after completing the transaction at $150.53 per share. On Aug 20 ’25, another insider, Hollar Jason M., who serves as the Chief Executive Officer of the company, sold 35,901 shares for $150.04 each. As a result, the insider received 5,386,566 and left with 200,000 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CAH now has a Market Capitalization of 36194009088 and an Enterprise Value of 41854951424. As of this moment, Cardinal’s Price-to-Earnings (P/E) ratio for their current fiscal year is 23.54, and their Forward P/E ratio for the next fiscal year is 14.25. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.84. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.16. Its current Enterprise Value per Revenue stands at 0.188 whereas that against EBITDA is 12.788.
Stock Price History:
The Beta on a monthly basis for CAH is 0.74, which has changed by 0.38495982 over the last 52 weeks, in comparison to a change of 0.13054323 over the same period for the S&P500. Over the past 52 weeks, CAH has reached a high of $168.44, while it has fallen to a 52-week low of $106.54. The 50-Day Moving Average of the stock is -4.66%, while the 200-Day Moving Average is calculated to be 9.91%.
Shares Statistics:
CAH traded an average of 2.20M shares per day over the past three months and 3141540 shares per day over the past ten days. A total of 239.00M shares are outstanding, with a floating share count of 237.63M. Insiders hold about 0.49% of the company’s shares, while institutions hold 88.11% stake in the company. Shares short for CAH as of 1753920000 were 5581420 with a Short Ratio of 2.54, compared to 1751241600 on 5631618. Therefore, it implies a Short% of Shares Outstanding of 5581420 and a Short% of Float of 3.08.
Dividends & Splits
With its trailing 12-month dividend rate of 2.028, CAH has a forward annual dividend rate of 2.03. Against a Trailing Annual Dividend Yield of 0.013259236The stock’s 5-year Average Dividend Yield is 2.68. The current Payout Ratio is 31.43% for CAH, which recently paid a dividend on 2025-07-01 with an ex-dividend date of 2025-10-01. Stock splits for the company last occurred on 2001-04-23 when the company split stock in a 3:2 ratio.
Earnings Estimates
The stock of Cardinal Health, Inc (CAH) is currently drawing attention from 13.0 analysts actively involved in the ongoing evaluation and rating process.The consensus estimate for the next quarter is $2.23, with high estimates of $2.39 and low estimates of $2.15.
Analysts are recommending an EPS of between $9.65 and $9.33 for the fiscal current year, implying an average EPS of $9.43. EPS for the following year is $10.62, with 14.0 analysts recommending between $11.03 and $10.36.
Revenue Estimates
It is expected that $90B in revenue will be generated in the current quarter, according to 12 analysts. It ranges from a high estimate of $60.24B to a low estimate of $57.57B. As of the current estimate, Cardinal Health, Inc’s year-ago sales were $52.28BFor the next quarter, 12 analysts are estimating revenue of $62.33B. There is a high estimate of $63.67B for the next quarter, whereas the lowest estimate is $60.79B.
A total of 14 analysts have provided revenue estimates for CAH’s current fiscal year. The highest revenue estimate was $250.36B, while the lowest revenue estimate was $242B, resulting in an average revenue estimate of $248.63B. In the same quarter a year ago, actual revenue was $222.58BBased on 14 analysts’ estimates, the company’s revenue will be $268.29B in the next fiscal year. The high estimate is $272.46B and the low estimate is $260B.
